Zika Infection May Bring Future Immunity: Study

Individuals, and large part of populations, may be protected against future epidemics, scientists say

By Robert Preidt

Friday, October 14, 2016

FRIDAY, Oct. 14, 2016 (HealthDay News) -- People who've been infected with Zika face a low risk for another bout with the virus that can cause birth defects, a new study contends.

"The research shows that infection provides excellent protection against reinfection," Stephen Higgs, director of the Biosecurity Research Institute at Kansas State University, said in a university news release.

"This means people infected during this current epidemic will likely not be susceptible again. When a large proportion of the population is protected -- known as herd immunity -- the risk of future epidemics may be low," he explained.

Higgs and his colleagues also found that Zika virus is present in the blood at the very early stages of infection and is only briefly present in some tissues. But it remains in other tissues for a long time.

Blood and urine were clear of Zika virus within 10 days, the investigators found. But for at least three weeks after it was no longer present in blood, the virus was still detectable in saliva and semen, the findings showed.

Further research is needed to learn how Zika invades the nervous system and how long and extensively Zika virus remains in saliva and semen, Higgs said. While the virus is typically spread through the bite of the Aedes aegypti mosquito, it can also be sexually transmitted.

The team also discovered better models for improving Zika virus research and more quickly testing vaccines.

The study findings were published Oct. 13 in the journal Nature Medicine.

For most people Zika infection is relatively harmless. But for pregnant women, it can cause the birth defect microcephaly, which results in babies born with abnormally small heads and brains.

SOURCE: Kansas State University, news release, Oct. 13, 2016

HealthDay

News stories are provided by HealthDay and do not reflect the views of MedlinePlus, the National Library of Medicine, the National Institutes of Health, the U.S. Department of Health and Human Services, or federal policy.